{"id":"https://openalex.org/W2012861083","doi":"https://doi.org/10.1177/0269881104040249","title":"Incidences of New Prescribing by British Child and Adolescent Psychiatrists: a Prospective Study Over 12 Months","display_name":"Incidences of New Prescribing by British Child and Adolescent Psychiatrists: a Prospective Study Over 12 Months","alternate_titles":[],"publication_year":2004,"publication_date":"2004-03-01","ids":{"openalex":"https://openalex.org/W2012861083","doi":"https://doi.org/10.1177/0269881104040249","mag":"2012861083","pmid":"https://pubmed.ncbi.nlm.nih.gov/15107194"},"language":"en","primary_location":{"id":"doi:10.1177/0269881104040249","doi":"https://doi.org/10.1177/0269881104040249","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881104040249","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2012861083"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086653909","display_name":"Andrew F. Clark","orcid":"https://orcid.org/0000-0002-3080-5833","observed_orcids":["https://orcid.org/0000-0002-3080-5833"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Andrew F. Clark","raw_affiliation_strings":["Department of Adolescent Psychiatry, University of Manchester and Regional Adolescent Unit, Bolton Salford Trafford Mental Health NHS Trust, Prestwich, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Adolescent Psychiatry, University of Manchester and Regional Adolescent Unit, Bolton Salford Trafford Mental Health NHS Trust, Prestwich, Manchester, UK","institution_ids":["https://openalex.org/I28407311"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5086653909"],"corresponding_institution_ids":["https://openalex.org/I28407311"],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":1.9978,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":{"value":0.84417248,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"18","issue":"1","first_page":"115","last_page":"120"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.3156999945640564,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.3156999945640564,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.2295999974012375,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10182","display_name":"Child and Adolescent Psychosocial and Emotional Development","score":0.18629999458789825,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/child-and-adolescent-psychiatry","display_name":"child and adolescent psychiatry","score":0.8479999899864197},{"id":"https://openalex.org/keywords/prescribing-patterns","display_name":"prescribing patterns","score":0.5120000243186951},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.5149999856948853},{"id":"https://openalex.org/keywords/child-mental-disorders","display_name":"child psychopathology","score":0.7360000014305115},{"id":"https://openalex.org/keywords/methylphenidate","display_name":"methylphenidate","score":0.8920000195503235},{"id":"https://openalex.org/keywords/stimulants","display_name":"stimulants","score":0.8560000061988831},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9580000042915344},{"id":"https://openalex.org/keywords/paroxetine","display_name":"paroxetine","score":0.9610000252723694},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.9710000157356262},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9940000176429749},{"id":"https://openalex.org/keywords/imipramine","display_name":"imipramine","score":0.9739999771118164},{"id":"https://openalex.org/keywords/d-amphetamine","display_name":"d-amphetamine","score":0.9860000014305115},{"id":"https://openalex.org/keywords/melatonin","display_name":"melatonin","score":0.9829999804496765},{"id":"https://openalex.org/keywords/service-variation","display_name":"service variation","score":0.5509999990463257},{"id":"https://openalex.org/keywords/north-west-england","display_name":"North West England","score":0.6650000214576721}],"concepts":[{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.7235813736915588},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.6903907060623169},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6752756237983704},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.6448065042495728},{"id":"https://openalex.org/C557119937","wikidata":"https://www.wikidata.org/wiki/Q1741745","display_name":"Child and adolescent psychiatry","level":2,"score":0.6148782968521118},{"id":"https://openalex.org/C134362201","wikidata":"https://www.wikidata.org/wiki/Q317309","display_name":"Mental health","level":2,"score":0.5589425563812256},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.4822293221950531},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.45164912939071655},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.44455888867378235},{"id":"https://openalex.org/C188313352","wikidata":"https://www.wikidata.org/wiki/Q119697","display_name":"Off-label use","level":2,"score":0.4329119026660919},{"id":"https://openalex.org/C2777828372","wikidata":"https://www.wikidata.org/wiki/Q408471","display_name":"Paroxetine","level":4,"score":0.43153390288352966},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.36796021461486816},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.3360480070114136},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.21670717000961304},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.18389886617660522},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.08361071348190308},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.0},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.0},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002665","descriptor_name":"Child Psychiatry","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004739","descriptor_name":"England","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D011307","descriptor_name":"Drug Prescriptions","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011619","descriptor_name":"Psychotropic Drugs","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1177/0269881104040249","doi":"https://doi.org/10.1177/0269881104040249","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881104040249","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:15107194","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15107194","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychopharmacology (Oxford, England)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9789000153541565}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1977866915","https://openalex.org/W1999991801","https://openalex.org/W2013651457","https://openalex.org/W2034063477","https://openalex.org/W2060706526","https://openalex.org/W2091074718","https://openalex.org/W2098954626","https://openalex.org/W2100419075","https://openalex.org/W2105472716","https://openalex.org/W2105777624","https://openalex.org/W2114776324","https://openalex.org/W2125778283","https://openalex.org/W2155916653","https://openalex.org/W2160214171","https://openalex.org/W2162865096","https://openalex.org/W4241230908","https://openalex.org/W4250277981","https://openalex.org/W4250858368"],"related_works":["https://openalex.org/W1992576609","https://openalex.org/W1999991801","https://openalex.org/W2794607170","https://openalex.org/W2021787109","https://openalex.org/W2013651457","https://openalex.org/W2058522220","https://openalex.org/W4388837177","https://openalex.org/W2076894470","https://openalex.org/W3033368051","https://openalex.org/W2508289190"],"abstract_inverted_index":{"Little":[0],"is":[1],"known":[2],"about":[3],"the":[4,9,19,79,99,146,169,188],"epidemiology":[5],"of":[6,11,23,25,38,87,101,136,148,155,159,166,171,180],"pharmacotherapy":[7],"in":[8,43,98,145,168],"treatment":[10,100,170],"child":[12,29,55,95,172,181],"psychiatric":[13,103,173],"disorder.":[14,104],"This":[15],"study":[16],"reports":[17],"on":[18],"systematic":[20],"prospective":[21],"collection":[22],"instances":[24,86],"new":[26,52],"prescribing":[27,53,149],"by":[28,54],"and":[30,48,56,64,76,131,157,182,196],"adolescent":[31,57,97,183],"mental":[32,58,184],"health":[33,59,185],"services":[34,60,144],"serving":[35],"a":[36,88,94,102,177],"population":[37],"approximately":[39],"four":[40],"million":[41],"people":[42],"North":[44],"West":[45],"England.":[46],"Diagnostic":[47],"demographic":[49],"information":[50],"regarding":[51],"within":[61],"Greater":[62],"Manchester":[63],"Lancashire":[65],"was":[66,140],"systematically":[67],"collected":[68],"prospectively":[69],"over":[70],"two":[71],"6-month":[72],"periods":[73],"between":[74,143,153],"2000":[75],"2002.":[77],"Within":[78],"12":[80],"months":[81],"studied,":[82],"there":[83],"were":[84,110,122],"845":[85],"drug":[89],"being":[90],"newly":[91],"prescribed":[92,111,120],"to":[93],"or":[96],"In":[105],"total,":[106],"48":[107],"different":[108,114],"drugs":[109,121],"for":[112,134],"25":[113],"diagnoses.":[115],"The":[116],"eight":[117],"most":[118],"commonly":[119],"methylphenidate,":[123],"methylphenidate/placebo":[124],"trial,":[125],"paroxetine,":[126],"fluoxetine,":[127],"risperidone,":[128],"imipramine,":[129],"dexamphetamine":[130],"melatonin,":[132],"accounting":[133],"73%":[135],"all":[137],"prescribing.":[138],"There":[139],"marked":[141],"variation":[142],"amount":[147],"with":[150],"significant":[151,178],"correlation":[152],"prescription":[154,158],"stimulants":[156],"selective":[160],"serotonin":[161],"reuptake":[162],"inhibitor":[163],"antidepressants.":[164],"Prescription":[165],"medications":[167],"disorder":[174],"has":[175],"become":[176],"part":[179],"practice.":[186],"However,":[187],"evidence":[189],"base":[190],"underpinning":[191],"this":[192],"usage":[193],"remains":[194],"limited,":[195],"further":[197],"high":[198],"quality":[199],"therapeutic":[200],"clinical":[201],"trials":[202],"are":[203],"urgently":[204],"needed.":[205]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2012861083","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
